Ignite Creation Date:
2024-05-05 @ 9:53 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00989586
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2009-10-02
Brief Title:
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Sponsor:
Beth Christian
Organization:
Ohio State University Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Waldenstrom macroglobulinemia | View |
| recurrent mantle cell lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| MALT lymphoma | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |
| recurrent marginal zone lymphoma | View |